Recently, the glycogen debranching enzyme amylo-α-1, 6-glucosidase, 4-α-glucanotransferase (AGL) was shown to have tumor suppressor functions in a model of urothelial bladder cancer [32]. This evidence concerns the gene AGL and neoplasm.